33530 Federal Register / Vol. 61, No. 125 / Thursday, June 27, 1996 / Notices

2. Capacity (55 total points)

a. Extent to which applicant describes

adequate resources and facilities for

conducting the project. Extent to which

facilities for the safe handling of

infectious agents are available. (10

points)

b. Extent to which applicant

documents that professional personnel

involved in the project are qualified and

have past experience and achievements

in research related to that proposed in

this cooperative agreement as evidenced

by curriculum vitae, publications, etc.

Extent to which the applicant

demonstrates experience with virology,

particularly the virology of measles

virus. (10 points)

c. Extent to which applicant

demonstrates experience with viral

pathogenesis/immunology in rhesus

macaques or other primate system.

Extent to which the applicant can

demonstrate previous or ongoing

experience with measles infections of

primates. Extent to which the applicant

can produce a measles infection that is

similar to measles infections in humans

in rhesus macaques following intranasal

inoculation. (35 points)

3. Objectives and Technical Approach

(35 total points)

a. Extent to which applicant describes

objectives of the proposed project which

are consistent with the purpose and

program requirements of this

cooperative agreement and which are

measurable and time-phased. (5 points)

b. Extent to which the plan clearly

describes applicant’s technical

approach/methods for conducting the

proposed studies. Extent to which

applicant describes specific study

protocols or plans for the development

of study protocols that are appropriate

for achieving project objectives. (10

points)

c. Extent to which applicant describes

appropriate collaboration with CDC

during various phases of the project. (10

points)

d. Extent to which applicant provides

a detailed plan for evaluating study

results and for evaluating progress

towards achieving project objectives. (10

points)

4. Budget (Not Scored)

Extent to which the proposed budget

is reasonable, clearly justifiable, and

consistent with the intended use of

cooperative agreement funds.

Executive Order 12372

Applications are not subject to review

under Executive Order 12372,

Intergovernmental Review of Federal

Programs.

Public Health System Reporting

Requirements

This program is not subject to the

Public Health System Reporting

Requirements.

Catalog of Federal Domestic Assistance

Number

The Catalog of Federal Domestic

Assistance Number is 93.283.

Other Requirements

Animal Subjects

This proposed project involves

research on animal subjects; therefore,

the applicant must comply with the

‘‘PHS Policy on Humane Care and Use

of Laboratory Animals by Awardee

Institutions.’’ An applicant organization

using vertebrate animals in PHSsupported activities must file an Animal

Welfare Assurance with the Office for

Protection from Research Risks at the

National Institutes of Health, Bethesda,

Maryland.

Application Submission and Deadline

The original and two copies of

application PHS Form 398 (Revised 5/

95, OMB Number 0925–0001) must be

submitted to Sharron P. Orum, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 314,

Mailstop E–18, Atlanta, GA 30305,

Attention: Marsha Driggans, on or before

August 12, 1996.

1. Deadline: Applications shall be

considered as meeting the deadline if

they are either:

a. Received on or before the deadline

date; or

b. Sent on or before the deadline date

and received in time for submission to

the independent review group.

(Applicants should request a legibly

dated U.S. Postal Service postmark or

obtain a legibly dated receipt from a

commercial carrier or U.S. Postal

Service. Private metered postmarks shall

not be acceptable proof of timely

mailing.)

2. Late Applications: Applications

which do not meet the criteria in 1.a. or

1.b., above, are considered late

applications. Late applications shall not

be considered in the current

competition for funding and will be

returned to the applicant.

Where To Obtain Additional

Information

A complete program description and

information on application procedures

are contained in the application

package. An application package and

business management and technical

assistance may be obtained from Marsha

Driggans, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Room 314, Mailstop E–18, Atlanta, GA

30305, telephone (404) 842–6523, Email mdd2@opspgo1.em.cdc.gov,

facsimile (404) 842–6513.

Programmatic technical assistance

may be obtained from Paul Rota, Ph.D.,

Supervisory Research Microbiologist,

Measles Section, Division of Viral and

Rickettsial Diseases, National Center for

Infectious Diseases, Centers for Disease

Control and Prevention (CDC), 1600

Clifton Road, NE., Mailstop G–17,

Atlanta, GA 30333, telephone (404)

639–3308, E-mail

par1@ciddvd1.em.cdc.gov, facsimile

(404) 639–1307.

Please refer to Announcement

Number 664 when requesting

information regarding this program.

Important Notice: Atlanta, GA, will be the

host of the 1996 Summer Olympics Games,

July 19 through August 4, 1996. As a result

of this event, it is likely that the Procurement

and Grants Office (PGO), CDC, may

experience delays in the receipt of both

regular and overnight mail deliveries.

Contacting PGO employees during this time

frame may also be hindered due to the

possible telephone disruptions. To the extent

authorized, please consider the use of voice

mail, E-mail, and facsimile transmission to

the maximum extent practicable. However,

do not fax lengthy documents or grant

applications.

You may obtain this announcement

from one of two Internet sites on the

actual publication date: CDC’s

homepage at http://www.cdc.gov or at

the Government Printing Office

homepage (including free on-line access

to the Federal Register at http://

www.access.gpo.gov).

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report: Stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report:

Stock No. 017–001–00473–1),

referenced in the Introduction, through

the Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325, telephone

(202) 512–1800.

Dated: June 21, 1996.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 96–16386 Filed 6–26–96; 8:45 am]

BILLING CODE 4163–18–P
Federal Register / Vol. 61, No. 125 / Thursday, June 27, 1996 / Notices 33531

Disease, Disability, and Injury

Prevention and Control Special

Emphasis Panel (SEP): Community

Partners for Healthy Farming, Program

Announcement 646, and Centers for

Agricultural Disease and Injury

Research, Education, and Prevention,

Program Announcement 647: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Disease, Disability, and Injury

Prevention and Control SEP: Community

Partners for Healthy Farming, Program

Announcement 646, and Centers for

Agricultural Disease and Injury Research,

Education, and Prevention, Program

Announcement 647.

Times and Dates: 8 p.m.–10 p.m., August

4, 1996; 8 a.m.–6 p.m., August 5, 1996; 8

a.m.–5 p.m., August 6, 1996.

Place: Commonwealth Hilton Hotel, I–75

and Turfway Road, Florence, Kentucky

45275.

Status: Closed.

Matters to be Discussed: The meeting will

include the review, discussion, and

evaluation of applications received in

response to Program Announcements 646

and 647.

The meeting will be closed to the public

in accordance with provisions set forth in

section 552b(c) (4) and (6), Title 5 U.S.C., and

the Determination of the Associate Director

for Management and Operations, CDC,

pursuant to Pub. L. 92–463.

Contact Person for More Information: Price

Connor, Ph.D., Research Grant Program

Officer, Office of Extramural Coordination

and Special Projects, National Institute for

Occupational Safety and Health, CDC, M/S

D30, 1600 Clifton Road, NE, Atlanta, Georgia

30333, telephone 404/639–3342.

Dated: June 21, 1996.

John C. Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 96–16390 Filed 6–26–96; 8:45 am]

BILLING CODE 4163–19–M

Health Care Financing Administration

[ORD–088–N]

New and Pending Demonstration

Project Proposals Submitted Pursuant

to Section 1115(a) of the Social

Security Act: May 1996

AGENCY: Health Care Financing

Administration (HCFA).

ACTION: Notice.

SUMMARY: One new proposal for a

Medicaid demonstration project was

submitted to the Department of Health

and Human Services during the month

of May 1996 under the authority of

section 1115 of the Social Security Act.

No proposals were approved,

disapproved, or withdrawn during this

time period. Those pending during the

month of May remain unchanged from

those in the Federal Register on June

10, 1996, 61 FR 29409. (This notice can

be accessed on the Internet at HTTP://

WWW.HCFA.GOV/ORD/

ORDHP1.HTML.)

COMMENTS: We will accept written

comments on these proposals. We will,

if feasible, acknowledge receipt of all

comments, but we will not provide

written responses to comments. We

will, however, neither approve nor

disapprove any new proposal for at least

30 days after the date of this notice to

allow time to receive and consider

comments. Direct comments as

indicated below.

ADDRESSES: Mail correspondence to:

Susan Anderson, Office of Research and

Demonstrations, Health Care Financing

Administration, Mail Stop C3–11–07,

7500 Security Boulevard, Baltimore, MD

21244–1850.

FOR FURTHER INFORMATION CONTACT:

Susan Anderson (410) 786–3996.

SUPPLEMENTARY INFORMATION:

I. Background

Under section 1115 of the Social

Security Act (the Act), the Department

of Health and Human Services (HHS)

may consider and approve research and

demonstration proposals with a broad

range of policy objectives. These

demonstrations can lead to

improvements in achieving the

purposes of the Act.

In exercising her discretionary

authority, the Secretary has developed a

number of policies and procedures for

reviewing proposals. On September 27,

1994, we published a notice in the

Federal Register (59 FR 49249) that

specified (1) the principles that we

ordinarily will consider when

approving or disapproving

demonstration projects under the

authority in section 1115(a) of the Act;

(2) the procedures we expect States to

use in involving the public in the

development of proposed demonstration

projects under section 1115; and (3) the

procedures we ordinarily will follow in

reviewing demonstration proposals. We

are committed to a thorough and

expeditious review of State requests to

conduct such demonstrations.

As part of our procedures, we publish

a notice in the Federal Register with a

monthly listing of all new submissions,

pending proposals, approvals,

disapprovals, and withdrawn proposals.

Proposals submitted in response to a

grant solicitation or other competitive

process are reported as received during

the month that such grant or bid is

awarded, so as to prevent interference

with the awards process.

II. Listing of New, Pending, Approved,

and Withdrawn Proposals for the

Month of May 1996

A. Comprehensive Health Reform

Programs

1. New Proposals:

The following comprehensive health

reform proposal was received during the

month of May:

Demonstration Title/State: Maryland

Medicaid Reform Proposal—Maryland.

Description: A statewide section 1115

demonstration proposal has been

developed to: provide a patient-focused

system through managed care entities;

build on the strengths of the current

Maryland health care system; provide

comprehensive, prevention-orientated

systems of care; hold Managed Care

Organizations (MCOs) accountable for

high-quality care; and achieve better

value and predictability for State

expenditures.

Date Received: May 3, 1996.

State Contact: Mary Mussman, M.D.,

M.P.H., Acting Executive Director,

Center for Health Program Development

and Management, Social Sciences

Building, Room 309A, 5401 Wilkens

Avenue, Baltimore, MD 21228–5398,

(410) 455–6804.

Federal Project Officer: Gina Clemons,

Health Care Financing Administration,

Office of Research and Demonstrations,

Office of State Health Reform

Demonstrations, Mail Stop C3–18–26,

7500 Security Boulevard, Baltimore, MD

21244–1850.

2. Pending, Approved, and Withdrawn

Proposals

We did not approve or disapprove any

proposals during the month of May nor

were any proposals withdrawn during

that month. Therefore, pending

proposals for the month of November

1995 published in the Federal Register

on January 23, 1996, 61 FR 1769, remain

unchanged.

B. Other Section 1115 Demonstration

Proposals

1. New Proposals

No new proposals were received

during the month of May.

2. Pending, Approved, and Withdrawn

Proposals

We did not approve or disapprove any

Other Section 1115 Demonstration

Proposals during May nor were any

proposals withdrawn during that